153 related articles for article (PubMed ID: 9825716)
21. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
22. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
23. What is an antiandrogen and what is the physiological and pharmacological rationale for combined "castration" + "antiandrogen" therapy.
Moguilewsky M; Cotard M; Proulx L; Tournemine C; Raynaud JP
Prog Clin Biol Res; 1987; 243A():315-40. PubMed ID: 3116549
[No Abstract] [Full Text] [Related]
24. Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?
Singer EA; Golijanin DJ; Messing EM
Can J Urol; 2008 Dec; 15(6):4381-7. PubMed ID: 19046491
[TBL] [Abstract][Full Text] [Related]
25. [Total androgen blockade therapy].
Sakai H; Kanetake H
Nihon Rinsho; 2000 Jul; 58 Suppl():197-201. PubMed ID: 11022713
[No Abstract] [Full Text] [Related]
26. Adjuvant treatment to radiation: combined hormone therapy and external radiotherapy for locally advanced prostate cancer.
Bolla M; Descotes JL; Artignan X; Fourneret P
BJU Int; 2007 Jul; 100 Suppl 2():44-7. PubMed ID: 17594359
[No Abstract] [Full Text] [Related]
27. Castration-resistant prostate cancer: descriptive yet pejorative?
Crawford ED; Petrylak D
J Clin Oncol; 2010 Aug; 28(23):e408. PubMed ID: 20547989
[No Abstract] [Full Text] [Related]
28. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
Morote J; Orsola A; Planas J; Trilla E; Raventós CX; Cecchini L; Catalán R
J Urol; 2007 Oct; 178(4 Pt 1):1290-5. PubMed ID: 17698136
[TBL] [Abstract][Full Text] [Related]
29. Delayed hormonal therapy in advanced prostatic cancer.
Zungri E; Salvador J; Chéchile G; Diaz I; Martinez E
Prog Clin Biol Res; 1987; 243B():441-7. PubMed ID: 3659038
[No Abstract] [Full Text] [Related]
30. Are organ preservation and maintenance of sexual function compatible with optimal management of prostate cancer? Part 2--Advanced cancer.
Pavone-Macaluso M
Prog Clin Biol Res; 1991; 370():203-5. PubMed ID: 1924452
[No Abstract] [Full Text] [Related]
31. Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
Anderson J; Abrahamsson PA; Crawford D; Miller K; Tombal B
BJU Int; 2008 Jun; 101(12):1497-501. PubMed ID: 18336613
[TBL] [Abstract][Full Text] [Related]
32. Prostatectomy or watchful waiting in prostate cancer.
Coen JJ; Zietman AL; Shipley WU
N Engl J Med; 2003 Jan; 348(2):170-1; author reply 170-1. PubMed ID: 12523306
[No Abstract] [Full Text] [Related]
33. Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.
Graff JN; Mori M; Li H; Garzotto M; Penson D; Potosky AL; Beer TM
J Urol; 2007 Apr; 177(4):1307-12. PubMed ID: 17382720
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer: new studies of combination therapy.
Harv Mens Health Watch; 2005 Jan; 9(6):5-7. PubMed ID: 15773010
[No Abstract] [Full Text] [Related]
35. Prostate cancer (non-metastatic).
Wilt T
Clin Evid; 2003 Dec; (10):1023-38. PubMed ID: 15555136
[No Abstract] [Full Text] [Related]
36. Prostate cancer (non-metastatic).
Wilt T
Clin Evid; 2003 Jun; (9):973-85. PubMed ID: 12967402
[No Abstract] [Full Text] [Related]
37. Treating prostate cancer. Part V: androgen deprivation and chemotherapy.
Harv Mens Health Watch; 1999 Dec; 4(5):5-8. PubMed ID: 10564905
[No Abstract] [Full Text] [Related]
38. [LHRH agonists in prostate cancer].
Rossi D; Cornu JN; Rouprêt M
Prog Urol; 2007 Apr; 17(2 Suppl 1):287-90. PubMed ID: 17569272
[No Abstract] [Full Text] [Related]
39. What to do if prostate cancer returns.
Johns Hopkins Med Lett Health After 50; 2001 Dec; 13(10):6-7. PubMed ID: 11727445
[No Abstract] [Full Text] [Related]
40. The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.
Ohlson N; Bergh A; Nygren K; Stattin P; Wikström P
Eur Urol; 2006 Apr; 49(4):675-83. PubMed ID: 16387414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
